P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells ; volume:12 ; number:1 ; day:12 ; month:6 ; year:2012 ; pages:1 ; date:6.2012
BMC complementary and alternative medicine ; 12, Heft 1 (12.6.2012), 1, 6.2012
- Urheber
-
Huh, J.
- Beteiligte Personen und Organisationen
-
Kang, J.
Baek, Y.
Choi, D.
Park, D.
Lee, J.
SpringerLink (Online service)
- DOI
-
10.1186/1472-6882-12-S1-P41
- URN
-
urn:nbn:de:1111-2016072933168
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huh, J.
- Kang, J.
- Baek, Y.
- Choi, D.
- Park, D.
- Lee, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models